chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I got COVID after I got two of the COVID shots; I got COVID after I got two of the COVID shots; had a sinus infection; Hard time breathing; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 61 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Polio vaccine (When I was a kid I got polio vaccine.), for Immunization.  The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "I got COVID after I got two of the COVID shots"; SINUSITIS (non-serious), outcome "unknown", described as "had a sinus infection"; DYSPNOEA (non-serious), outcome "unknown", described as "Hard time breathing". The patient underwent the following laboratory tests and procedures: sars-cov-2 test positive: i got covid after i got two of the covid shots, notes: I got COVID after I got two of the COVID shots. Clinical Course: The patient stated I got COVID after I got two of the COVID shots, I was four days away from getting my booster and on the top of that I got the sinus infection." When I was a kid I got polio vaccine then none of us got polio.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Eczema type lesions appeared initially on legs and then spread to entire body (sporadically).  Started out with 1 then after a week got a couple of more, and then continued to spread further.  Seems to be an immune response? Never had eczema before in my entire life.  The eczema is not itchy or painful,  the spots are just there.  This may be nothing, but thought I should report it.
The vaccines were given at 3:00 pm and at 10:00 pm the child began to scream and cry inconsolably and did not quit until 2:00 am. The child had been given proper doses of Tylenol at proper intervals.
Pt. Autoimmune Hepatitis had been controlled with medication for 4 years, his Hepatology doctors began monitoring his bloodwork after the first vaccine on January 3, 2021, after his 2nd vaccine, we received a phone call on February 26, 2021 from NP with the clinic, she said his liver enzymes were elevated, on March 22nd he was in the ER with Ascites, that's when we learned he had blood clots and esophageal varices.  On April 19th patient was transfered to hospital where he underwent a liver transplant on May 16, 2021, the blood clots in his portal vein complicated the transplant
lymph nodes on the left side of the back of my head, and in my neck and under my arm were painful and swollen; lymph nodes on the left side of the back of my head, and in my neck and under my arm were painful and swollen; I could feel the warmth of them in my body, like a fever; headache; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in arm left as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient took the first dose of the Pfizer BioNTech covid vaccine and a week later the lymph nodes on the left side of the back of her head, and in her neck and under her arm were painful and swollen.  She could feel the warmth of them in her body, like a fever. She had a headache.  She got the shot on the left side.  She's supposed to get the second shot next week, and she's wondering if she should get the next dose since she's having these side effects. Outcome of the events was not recovered.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Patient passed out for several seconds, shaking and felt confused. He was examined by Dr. and started feeling better.
Patient had the following after his covid booster: -arm pain at injection site - began soon after injection, continues to be sore 2 days post injection - soreness in armpit (suspected from swollen lymph nodes) - began morning after injection, still present but is improving 2 days post injection - fatigue - day after injection only - unusually tired from first thing in the morning, througout school day and took nap after school - chills -day after injection only -  was unusually cold during school day -  decreased appetite - day after injection only -  disturbed sleep - 2 nights after injection - woke up with unusual frequency - headache - 2 days after injection - had headache during school day, resolved without meds  The only symptom patient had after his initial covid vaccine series was a sore arm.
Systemic: Fainting / Unresponsive-Mild, Additional Details: PATIENT FAINTED WITHIN 15 MINUTES OF VACCINE, ABOUT NOON. SHE RECOVERED WITHIN 5-10 MINUTES. THE PARAMEDICS CAME AND CHECKED HER VITALS AND WERE NORMAL. PATIENT WENT THEN HOME WITH MOM. I SPOKE WITH MOM AT 6PM when store closed AND MOM SAID Patient WAS DOING OK.
Pt vax /w Engerix-B non-responders booster doses are planned for pt who did not seroconvert while on Engerix-B.
is going to the toilet so many times; urinary incontinence; This spontaneous case was reported by a consumer and describes the occurrence of POLLAKIURIA (is going to the toilet so many times) and URINARY INCONTINENCE (urinary incontinence) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     Concurrent medical conditions included Gout.    On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced POLLAKIURIA (is going to the toilet so many times) and URINARY INCONTINENCE (urinary incontinence). At the time of the report, POLLAKIURIA (is going to the toilet so many times) and URINARY INCONTINENCE (urinary incontinence) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information provided included unknown medication for Gout.
This spontaneous report as received from a licensed practical nurse refers to a 15 month ol patient of unknown gender. No pertinent medical history or drug reactions/allergies were provided. The nurse reported that, on 16-DEC-2014, the patient was vaccinated with VARIVAX (Merck) inj that was improperly stored (0.5 ml once. subcutaneously; lot number not provided). No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
I developed a itch rash on my wrist and I thought I had poison ivy. It traveled up my arm. I had a telehealth visit and they started me on prednisone which made the rash clear up after 3 days.
Difficulty swallowing x 20min after vaccination. Benadryl, 50mg PO.
Persistent pain (day & night) under left armpit for 4 days- lymph node?  Unable to sleep on left side
PT COMPLAINED OF SEVERE PAIN AT THE INJECTION SITE ONE WEEK AFTER RECEIVING INJECTION.
Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Systemic: Flushed / Sweating-Mild, Systemic: Tingling (specify: facial area, extemities)-Medium, Systemic: Visual Changes/Disturbances-Mild, Additional Details: Patient started experiencing rediness on the face and behind the ears area, along with itchy sensation around the throat area after the bivalent administration. Patient had 1st and 2nd monovalent shot with no issues. Benadryl and epi-pen was administered. Patient denied the call for 911 and ambulance and patient insisted to have her boyfriend to drive her to the Emergency room.
Neuropathy in his lower extremities and hands; Confusion; Intense headaches; This serious case was reported by a physician via sales rep and described the occurrence of neuropathy in a elderly male patient who received Herpes zoster (Shingrix) for prophylaxis.   In JUN-2023, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced neuropathy (Verbatim: Neuropathy in his lower extremities and hands) (serious criteria GSK medically significant), confusion (Verbatim: Confusion) and headache (Verbatim: Intense headaches). The outcome of the neuropathy, confusion and headache were resolved (duration 24 hrs).   It was unknown if the reporter considered the neuropathy, confusion and headache to be related to Shingrix.     It was unknown if the company considered the neuropathy, confusion and headache to be related to Shingrix.   Additional Information: GSK receipt date: 17-JUL-2023 The patient, who is an Internal Medicine physician, received his first dose of Shingrix in mid-June 2023 and experienced more than the usual and expected adverse events including severe neuropathy in his lower extremities and hands which lasted for approximately 24 hours.  In addition, patient also experienced confusion where, for example, patient could not add 15 plus 2.  The patient also experienced intense headaches and confusion all over a 24 hour duration, when these symptoms resolved itself. The reporter consented to follow up.
Information has been received from a physician concerning a 7 year old male who on 21-MAY-2001 was vaccinated with a first dose of MMR II.  On 07-JUN-2004 the patient was vaccinated with a second dose of MMR II.  It was reported that the patient did not received the third dose of MMR II.  On 22-JAN-2010 the patient experienced mumps.  The patient was diagnosed with mumps on 24-JAN-2010.  Other symptoms presented by the patient included left parotitis, swelling and fever of 100.2 degrees F.  First blood work test performed on 25-JAN-2010 included IgM (<1:10), IgG (2.39) and amylase (26).  Second blood work was not performed.  The final outcome for mumps was not reported.  This is one of several reports from the same source.  No further information is available.
This spontaneous report as received from a pharmacist refers to a 69 years old female patient with no drug reaction/allergies and no pertinent medical history, who on 12-JUL-2012 was vaccinated with a dose of ZOSTAVAX dose not reported) subcutaneously (lot # 671076/1198AA, Exp. 25-OCT-2012). No other co-suspects were reported. No concomitant medications were reported. On 13-JUL-2012 the patient developed soreness and red rash at the injection site. The patient was seen at a local urgent care facility but no treatment was prescribed. On 16-JUL-2012, the pharmacist spoke with the patient and her symptoms had not improved. The patient was planning on consulting with her unspecified physician. No laboratory diagnostic studies were performed. No treatment was given. Additional information is not expected.
Shingles; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, immediately after receiving Shingles vaccine, the patient experienced shingles (Verbatim: Shingles). The outcome of the shingles was not reported.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.     It was unknown if the company considered the shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 15-JUN-2023 This case was reported via interactive digital media. The reporter knowns the patient who got the Shingles vaccine shot immediately got shingles. The follow-up could not be possible as no contact details were available. This case is linked with US2023AMR084564 and US2023AMR084559, reported by same reporter.; Sender's Comments:  US-GSK-US2023AMR084559:Same reporter/Original case US-GSK-US2023AMR084564:Same reporter
Lump in his arm pit; Pain in left arm near the shoulder; Sweatiness; Fever; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY MASS (Lump in his arm pit), PAIN IN EXTREMITY (Pain in left arm near the shoulder), HYPERHIDROSIS (Sweatiness) and PYREXIA (Fever) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced AXILLARY MASS (Lump in his arm pit), PAIN IN EXTREMITY (Pain in left arm near the shoulder), HYPERHIDROSIS (Sweatiness) and PYREXIA (Fever). On 21-Mar-2021, PAIN IN EXTREMITY (Pain in left arm near the shoulder), HYPERHIDROSIS (Sweatiness) and PYREXIA (Fever) had resolved. At the time of the report, AXILLARY MASS (Lump in his arm pit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.
Immediate onset Rapid heartbeat, headache, nausea, extreme immediate fatigue onset  Treatment: Atarax, benadryl, extra strength Tylenol, Hydrochloathiazide
woke up with EXTREMELY painful joints....i was tearful during movement...entire body-worse pain than any arthritis flare i have ever had. my fingers/hands were extremely painful.  my neck was sore throughout the day and night, sore throat, stuffiness...  my entire body felt like i had the flu. at 1st i was afraid i may have covid because i had an hour or two later in afternoon that i was experiencing a taste and smell of a metallic something. i had an initial temp of 101.8. my temp averaged 101 over the course of the day and night.  i was very tired all day and night. i developed an itchy nonraised rash on my abdomen at around 5:00 pm.  so i took a benadryl. i also took my hydrocodone 4 x from morning until  11 pm when i was finally able to fall asleep.  it helped with the pain for only a few hours at a time. i actually went back to bed early afternoon- which is totally uncharacteristic for me.
In June went to the hospital emergency with numbness in both arms and legs, fore arms and lower legs had a burning sensation  still have it today.  Was in the hospital for three days testing  no conclusion. MRI in Sept. scan came back with no issues had electrical stimulation test no reason as to why my fore arms  and lower legs still have a burning sensation and both go numb from time to time. Now i am getting more frequent headaches. Thought this could be related to lyme disease but discovered a relative has similar issues
pt recv vax 18NOV98 & 20NOV98 pt died (SIDS);
Expired Havrix administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 10-year-old female patient who received HAV (Havrix 720) (batch number EP47E, expiry date 06-FEB-2023) for prophylaxis.   On 06-MAR-2023, the patient received the 2nd dose of Havrix 720. On 06-MAR-2023, an unknown time after receiving Havrix 720, the patient experienced expired vaccine used (Verbatim: Expired Havrix administered). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 08-MAR-2023 The medical assistant reported that a patient was administered with a dose of expired Havrix vaccine. This was the second dose in the series for the patient.  At the time of reporting, the dose had not been repeated. The Vaccine Administration Facility was the same as Primary Reporter. The reporter consented to follow up. HCP gave permission for follow-up. Patient received a dose of Havrix on 6th March 2023 which was expired on 6th February 2023, which led to expired vaccine used. This case is linked with US2023036748, reported by the same reporter.; Sender's Comments:  US-GSK-US2023036748:Same reporter
On 11-12-2008 after a field trip from school L deltoid- red, swollen, warm to touch a area estimated 9cm by 9cm.
From initial information received on 05/23/2003 from a physician regarding an adverse event occurring in the USA, it was reported that a two month old female patient received ActHIB, Lot # UA839AA, IPOL, Lot # W0750, TRIPEDIA, Lot # U0855AA, and PREVNAR, Lot # 492393 (manufactured by Wyeth), adminstered on 05/13/2003.  The same day, the patient became extremely irritable, with poor sleep and poor nursing.  These symptoms persisted over the next 72 hours.  The patient reportedly recovered from this event.  The reporter of this case is the same reporter of case 2003-01025.
headache; nausea; hot; This is a spontaneous report from a contactable consumer (patient herself).  A 76-year-old non pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number: EL8982, Expiry date was not reported), via an unspecified route, administered in the left arm on 22Jan2021 as dose 1, single for COVID-19 immunization. The patient was not pregnant at time of vaccination. The facility type vaccine was public health department. The patient's medical history and concomitant medications were not reported. The patient felt fine all weekend unlike the first one which she had a headache and nausea on 20Feb2021 at 18:00, then the a week later it started on Saturday night very hot on Sunday headache and nausea, this tuesday she still feel bad she understand this can happen up to 1 to 2 weeks after this normal this long she still work been out for 2 days if she cannot work tomorrow she has to have a Dr excuse how long does it go on. The patient receives Pfizer in the left arm on 12Feb2021 at 12:30 (Batch/Lot number: EN6201) other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medication within two weeks of vaccination. The patient did not received treatment for the events. The clinical outcome for the events was unknown.  Follow-up attempts completed. No further information expected.
Shot was given too high in right arm.  Nearly on top of shoulder. The pain in my shoulder is getting worse by the day. I cannot move my arm without severe pain
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 75-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 31Mar2022 as dose 4 (booster), single (Lot number: FM0698) at the age of 75 years, in right arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 28Jan2021 as dose 1, single (Lot number: 044L20N), in right arm, on 02Mar2021 as dose 2, single (Lot number: 011A21A), in right arm and on 02Nov2021 as dose 3 (booster), single (Lot number: 033F21A), in right arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive; Negative. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: No Other medication in 2 weeks. Anti-viral details: product-COVID 19 Treatment, brand-Pfizer, treatment start date-10May2022, treatment stop date-14May2022, lot number-unknown, indication-Treatment of COVID-19.
Started with diarrhea the day after her vaccination. Daughter was fussy and seemed to be in pain and not eating much. Patient died at hospital on 04/06/2017. Hospital 1: Medical Center ER, transferred to another city via helicopter. Hospital 2: Hospital.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was provided regarding the patient's past medical history, concurrent conditions, or concomitant medication. In 2012, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) at a pharmacy as recommended for routine adult health maintenance and for the long-term prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster or shingles. Later in 2012, the patient was treated by a medical center/hospital (by an unspecified healthcare professional) for the onset of a vesicular rash, which was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and or despite receiving ZOSTAVAX for the long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the herpes zoster was unknown. Causality assessment was related. Additional information has been requested.
I was feeling achy and itchy on upper right side of back/Achiness spread to underarm in the next couple days; I was feeling achy and itchy on upper right side of back; I had a few tiny pimple looking spots; red blotches appeared between my back and underarm; shingle; This is a spontaneous report from a contactable consumer (patient herself). A 42-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EW0168), via an unspecified route of administration, administered in Arm Left on 19May2021 at 14:00 (at the age of 42-years-old) as unknown, single dose for COVID-19 immunization. The patient medical history was not reported. Concomitant medications included spironolactone; escitalopram oxalate (LEXAPRO); cannabidiol and (vitamins nos). The patient had no other vaccine in four weeks. The patient not had covid prior vaccination. Consumer stated that, few days after vaccination she was feeling achy and itchy on upper right side of back. She had a few tiny pimple looking spots, but nothing looked concerning. Achiness spread to underarm in the next couple days and then raised red blotches appeared between her back and underarm. Achiness and itching now spread to side of right breast. Doctor's office diagnosed her today with shingles. On 23May2021, the patient experienced Few days after vaccination, I was feeling achy and itchy on upper right side of back/Achiness spread to underarm in the next couple days, I was feeling achy and itchy on upper right side of back, I had a few tiny pimple looking spots but nothing looked concerning. Achiness spread to underarm in the next couple days and then raised red blotches appeared between my back and underarm. Achiness and itching now spread to side of right breast. Therapeutic measures were taken as a result of events and treatment included with Starting an antiviral for 7 days. The patient had not tested covid post vaccination. The outcome of the events was not recovered.